Holen Sie sich die Stockscreener-App
5.13
3.64%
0.18
Handel nachbörslich:
5.13
Bolt Biotherapeutics Inc Aktie (BOLT) Neueste Nachrichten
Bolt Biotherapeutics, Inc. (BOLT) reports Q1 loss, lags revenue estimates - MSN
Bolt Biotherapeutics, Inc.Common Stock (NQ: BOLT - The Chronicle-Journal
Bolt Biotherapeutics: Cash on Hand Is Expected to Fund Ops Into 2027 - Moomoo
Press Release: Bolt Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Business Update - Moomoo
Bolt Biotherapeutics Reports First Quarter 2026 Financial Results - TradingView
Bolt Biotherapeutics, Inc. (BOLT) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance
Bolt Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Business Update - The Manila Times
Bolt Biotherapeutics Inc.: Q1 Earnings Snapshot - marketscreener.com
Bolt Biotherapeutics 1Q 2026: Revenue $26K, Net loss $7.24M, EPS $(4.31) — 10-Q Summary - TradingView
Bolt Biotherapeutics (NASDAQ: BOLT) narrows Q1 loss, cuts expenses - Stock Titan
Cancer drug trial data due in 3Q 2026 as Bolt logs $7.6M operating loss - Stock Titan
BOLT (Bolt Bio) beats earnings estimates as quarterly loss narrows 38 percent, but stock flat.Asset Sale - newser.com
Bolt Biotherapeutics Inc expected to post a loss of $2.85 a shareEarnings Preview - TradingView
BOLT Q1'26 Earnings: EPS estimate is (2.85) USD - TradingView
Bolt Biotherapeutics (BOLT) 2026 proxy details director votes and auditor - Stock Titan
[ARS] Bolt Biotherapeutics, Inc. SEC Filing - Stock Titan
Is Bolt Bio (BOLT) stock moving unpredictably (Trend Strengthens) 2026-04-20Community Pattern Alerts - Cổng thông tin điện tử Tỉnh Sơn La
Operating cash flow per share of Bolt Biotherapeutics, Inc. – MUN:6LP0 - TradingView
Aug Movers: Is Bolt Biotherapeutics Inc still a buy after recent gainsMarket Activity Summary & Verified Momentum Stock Ideas - baoquankhu1.vn
Treasury Yields: Will Bolt Biotherapeutics Inc announce a stock splitWeekly Loss Report & Daily Volume Surge Trade Alerts - baoquankhu1.vn
What is the price target for Bolt Bio (BOLT) Stock | Price at $4.75, Up 5.21%Verified Signals - Newser
BOLT STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Bolt Biotherapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Is momentum building in Bolt Bio (BOLT) Stock | Price at $4.81, Up 0.63%Percent Below MA - Newser
Performance Recap: Is Bolt Biotherapeutics Inc still a buy after recent gains2026 Buyback Activity & Stepwise Swing Trade Plans - baoquankhu1.vn
Is Bolt Bio (BOLT) Stock Ready to Drop | Price at $4.56, Up 6.29%Crowd Sentiment Stocks - Newser
BOLT Uptrend Accelerates on Market - newser.com
Technical Analysis: Will Bolt Biotherapeutics Inc announce a stock splitTrade Exit Report & Community Consensus Stock Picks - baoquankhu1.vn
Sentiment Watch: Is Bolt Biotherapeutics Inc on track to beat earnings2026 Outlook & Precise Swing Trade Entry Alerts - baoquankhu1.vn
Income Plays: Is Bolt Biotherapeutics Inc impacted by rising ratesEarnings Summary Report & Weekly Setup with High ROI Potential - baoquankhu1.vn
Entry Recap: Is Bolt Biotherapeutics Inc undervalued by DCF analysisInsider Selling & High Conviction Investment Ideas - baoquankhu1.vn
Institution Moves: What is the long term forecast for Bolt Biotherapeutics Inc stock2026 Price Action Summary & Growth Focused Entry Reports - baoquankhu1.vn
Fund Flows: Is Bolt Biotherapeutics Inc still a buy after recent gains2026 Breakouts & Weekly Return Optimization Alerts - baoquankhu1.vn
Aug Sectors: What are Bolt Biotherapeutics Incs earnings expectationsTrade Entry Report & AI Powered Market Entry Ideas - baoquankhu1.vn
Momentum Shift: Is Bolt Biotherapeutics Inc still a buy after recent gains2026 Institutional & Stepwise Trade Signal Guides - baoquankhu1.vn
Trend Recap: Will Bolt Biotherapeutics Inc outperform its industry peersWeekly Trade Analysis & Long Hold Capital Preservation Tips - baoquankhu1.vn
Bolt Biotherapeutics discloses new STING agonist immunoconjugates - BioWorld News
Bronstein, Gewirtz and Grossman, LLC sends a Class Action Lawsuit reminder to shareholder investors for Bolt Biotherapeutics, Inc. to Lead the Class Action Lawsuit! - ACCESS Newswire
CEO Change: Is Bolt Biotherapeutics Inc on track to beat earnings2026 Chart Watch & Technical Pattern Recognition Alerts - baoquankhu1.vn
Bolt Biotherapeutics (BOLT) to Release Quarterly Earnings on Wednesday - Defense World
If You Invested $1,000 in Bolt Biotherapeutics, Inc. (BOLT) - Stock Titan
Buyout Rumor: Is Bolt Biotherapeutics Inc undervalued by DCF analysisInsider Buying & Technical Pattern Based Signals - baoquankhu1.vn
Market Outlook: Is Bolt Biotherapeutics Inc likely to announce a buybackEarnings Miss & Short-Term Swing Trade Alerts - baoquankhu1.vn
Market Leaders: Is Bolt Biotherapeutics Inc likely to announce a buyback2026 Action & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Sell Signal: Will Bolt Biotherapeutics Inc outperform its industry peersPortfolio Gains Summary & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
What is the long term forecast for Bolt Biotherapeutics Inc stock2026 News Drivers & Fast Gain Stock Tips - baoquankhu1.vn
Weekly Earnings: Is Bolt Biotherapeutics Inc stock a smart retirement pick2026 Bull vs Bear & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Fundamentals Check: Does Bolt Biotherapeutics Inc have strong EBITDA margins2026 Bull vs Bear & Community Consensus Trade Signals - baoquankhu1.vn
Whats the outlook for Bolt Biotherapeutics Incs sector2026 Analyst Calls & Long Hold Capital Preservation Plans - baoquankhu1.vn
Market Outlook: Is Bolt Biotherapeutics Inc stock a smart retirement pick2026 Weekly Recap & High Conviction Trade Alerts - baoquankhu1.vn
HC Wainwright Reiterates Buy Rating for Bolt Biotherapeutics (BO - GuruFocus
Bolt Biotherapeutics Inc.: Q4 Earnings Snapshot - theheraldreview.com
Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update - Bitget
Bolt Biotherapeutics 2025 Financials: Loss Narrows to $33.4MNews and Statistics - IndexBox
Bolt Biotherapeutics, Inc. (BOLT) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Bolt Biotherapeutics Inc.: Fourth Quarter Financial Results Overview - Bitget
BOLT Reports Q4 Revenue Surpassing Expectations - GuruFocus
Bolt Biotherapeutics 10-K: $7.7M Revenue, $(17.85) EPS - TradingView
Bolt Biotherapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
0.98%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):